| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 628682 | Null | 0.000967118311825486 | 0.20762102 |
| NSC 693117 | Null | 0.000967118311825486 | 0.4005872 |
| NSC 643006 | Null | 0.00104257542638397 | 0.30542975 |
| NSC 707909 | Null | 0.00104257542638397 | 0.44924971 |
| NSC 683048 | Null | 0.0013187520236934 | 0.17768411 |
| NSC 224131 | N-Phosphonacetyl-L-aspartate | 0.00134664791567076 | 0.1928692 |
| NSC 344505 | 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- | 0.00134664791567076 | 0.36233174 |
| NSC 106557 | 5.alpha.,25D-Spirostan-3.beta.-ol glycoside | 0.00162803849483079 | 0.20164513 |
| NSC 357114 | CS-12350 | 0.00162803849483079 | 0.029457137 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.00162803849483079 | 0.034607978 |